4.6 Article

Negative feedback loop of bone resorption by NFATc1-dependent induction of Cadm1

期刊

PLOS ONE
卷 12, 期 4, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0175632

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan
  2. Grants-in-Aid for Scientific Research [17H03580, 26290035, 26253075] Funding Source: KAKEN

向作者/读者索取更多资源

Trimethylation of histone H3 lysine 4 and lysine 27 (H3K4me3 and H3K27me3) at gene promoter regions critically regulates gene expression. Key developmental genes tend to exhibit changes in histone modification patterns from the H3K4me3/H3K27me3 bivalent pattern to the H3K4me3 monovalent pattern. Using comprehensive chromatin immunoprecipitation followed by sequencing in bone marrow-derived macrophages (BMMs) and mature osteoclasts, we found that cell surface adhesion molecule 1 (Cadm1) is a direct target of nuclear factor of activated T cells 1 (NFATc1) and exhibits a bivalent histone pattern in BMMs and a monovalent pattern in osteoclasts. Cadm1 expression was upregulated in BMMs by receptor activator of nuclear factor kappa B ligand (RANKL), and blocked by a calcineurin/ NFATc1 inhibitor, FK506. Cadm1-deficient mice exhibited significantly reduced bone mass compared with wild-type mice, which was due to the increased osteoclast differentiation, survival and bone-resorbing activity in Cadm1-deficient osteoclasts. These results suggest that Cadm1 is a direct target of NFATc1, which is induced by RANKL through epigenetic modification, and regulates osteoclastic bone resorption in a negative feedback manner.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Disease activity affects the recurrent deformities of the lesser toes after resection arthroplasty for rheumatoid forefoot deformity

Taro Kasai, Gen Momoyama, Yuichi Nagase, Tetsuro Yasui, Sakae Tanaka, Takumi Matsumoto

Summary: This study suggests that disease activity has an impact on recurrent deformities of the lesser toes in patients with rheumatoid arthritis after resection arthroplasty for forefoot deformities, while recurrent deformities of the hallux are associated with the severity of preoperative hallux deformity.

MODERN RHEUMATOLOGY (2021)

Review Endocrinology & Metabolism

RANKL as a therapeutic target of rheumatoid arthritis

Sakae Tanaka, Yoshiya Tanaka

Summary: RANKL plays a critical role in rheumatoid arthritis, with Denosumab being an effective therapeutic option.

JOURNAL OF BONE AND MINERAL METABOLISM (2021)

Correction Endocrinology & Metabolism

RANKL as a therapeutic target of rheumatoid arthritis (Oct, 10.1007/s00774-020-01159-1, 2020)

Sakae Tanaka, Yoshiya Tanaka

Summary: The original publication of the article contained an error in the title of the table, which should have been Baseline patient demographics and characteristics in DESIRABLE trial. This title was adopted from a reference with permission.

JOURNAL OF BONE AND MINERAL METABOLISM (2021)

Review Endocrinology & Metabolism

Sclerostin: from bench to bedside

Sakae Tanaka, Toshio Matsumoto

Summary: Sclerostin negatively regulates canonical Wnt signaling pathways by binding to LRP5/6, while Romosozumab, a specific anti-sclerostin antibody, indirectly activates this pathway to promote bone formation.

JOURNAL OF BONE AND MINERAL METABOLISM (2021)

Article Endocrinology & Metabolism

Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study

Sakae Tanaka, Hideki Mizutani, Eri Tsuruya, Ryoko Fukuda, Kiyoka Kuge, Naoki Okubo

Summary: The study confirmed the long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis in daily clinical practice. It showed significant improvements in bone density and reductions in bone turnover markers, with a low incidence of osteoporotic fractures over 3 years. No new safety signals were identified.

JOURNAL OF BONE AND MINERAL METABOLISM (2021)

Article Rheumatology

Systemic inflammatory responses after orthopedic surgery in patients with rheumatoid arthritis treated with tofacitinib

Uchio Akihiro, Takumi Matsumoto, Yuji Maenohara, Yasunori Omata, Hiroshi Takahashi, Mitsuyasu Iwasawa, Takuo Juji, Ichiro Nakamura, Sakae Tanaka

Summary: The study found that tofacitinib did not suppress the postoperative increase in body temperature and CRP level, but may lead to a decrease in lymphocyte count. The timing for resuming tofacitinib treatment after surgery should be carefully considered.

CLINICAL RHEUMATOLOGY (2021)

Article Multidisciplinary Sciences

Offset nail fixation for intertrochanteric fractures improves reduction and lag screw position

Takehiro Matsubara, Kazuhito Soma, Ikufumi Yamada, Hiroshi Fujita, Junya Yoshitani, Hiroyuki Oka, Hiroyuki Okada, Sakae Tanaka

Summary: Surgery for intertrochanteric fractures using intramedullary hip nails with an anterior offset (Best Fit Nail) has been found to be more effective in maintaining fragment reduction and proper lag screw position compared with conventional non-offset nails (Proximal Femoral Nail Antirotation), according to postoperative computed tomography evaluation.

PLOS ONE (2022)

Article Medicine, General & Internal

Practical guidance to handle missing values in the 25-question Geriatric Locomotive Function Scale (GLFS-25): a simulation study

Takuya Kawahara, Keiko Yamada, Ryohei Terashima, Ikumi Takashima, Sakae Tanaka, Toru Ogata, Hirotaka Chikuda, Hiromasa Miura, Kozo Nakamura, Takashi Ohe

Summary: Multiple imputation was found to be the preferable method for handling missing values in the GLFS-25 questionnaire. However, single imputation using subject average/subject domain average can be used with practically negligible bias as long as the number of missing items is up to 8 out of 25 items in each individual of the population.

BMJ OPEN (2022)

Article Rheumatology

Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate: a randomised, double-blind, phase IIa trial

Tsutomu Takeuchi, Sakae Tanaka, Mitsuru Murata, Yoshiya Tanaka

Summary: This study aimed to evaluate the efficacy and safety of TAS5315 in Japanese patients with refractory rheumatoid arthritis. The results showed numerical differences in disease activity improvement rates between the TAS5315 group and the placebo group at week 12, but the primary endpoint was not achieved. However, TAS5315 demonstrated advantages in disease activity and biomarker improvement, as well as higher risk of bleeding events within 36 weeks. Therefore, a risk-benefit analysis of TAS5315 should be considered.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Changes in knee joint destruction patterns among patients with rheumatoid arthritis undergoing total knee arthroplasty in recent decades

Ryutaro Takeda, Takumi Matsumoto, Yasunori Omata, Hiroshi Inui, Shuji Taketomi, Yuichi Nagase, Takuji Nishikawa, Hiroyuki Oka, Sakae Tanaka

Summary: This study investigated the trend of joint destruction patterns on knee radiographs of patients with rheumatoid arthritis (RA) undergoing total knee arthroplasty (TKA) over the past 16 years. The results showed that radiographs of TKA recipients with RA are increasingly presenting osteoarthritic features in recent decades. The study also identified different clusters based on radiographic findings, indicating variations in joint space narrowing, spur formation, and alignment.

CLINICAL RHEUMATOLOGY (2023)

Article Orthopedics

Patterns of symptoms and insufficiency fractures in patients with tumour-induced osteomalacia

H. Kobayashi, N. Ito, Y. Nakai, H. Katoh, K. Okajima, L. Zhang, Y. Tsuda, S. Tanaka

Summary: The aim of this study was to report the patterns of symptoms and insufficiency fractures in patients with tumour-induced osteomalacia (TIO) for early diagnosis. The study included 33 TIO patients treated between January 2000 and June 2022. Symptoms and radiological patterns of insufficiency fractures were investigated. The results showed that TIO patients experienced back pain, chest wall pain, and hip pain, with vertebral fractures being biconcave deformities and periarticular fractures involving subchondral insufficiency fractures and epiphyseal or metaphyseal fractures. The presence of these symptoms and insufficiency fractures in patients with a tumor should suggest TIO diagnosis.

BONE & JOINT JOURNAL (2023)

Article Cell & Tissue Engineering

Nutrient-regulated dynamics of chondroprogenitors in the postnatal murine growth plate

Takeshi Oichi, Joe Kodama, Kimberly Wilson, Hongying Tian, Yuka Imamura Kawasawa, Yu Usami, Yasushi Oshima, Taku Saito, Sakae Tanaka, Masahiro Iwamoto, Satoru Otsuru, Motomi Enomoto-Iwamoto

Summary: Long bone growth in the growth plate relies on endochondral ossification through the accumulation and synthesis of matrix scaffold by chondrocytes. Nutritional restriction increases the number of chondroprogenitors in the resting zone and inhibits their differentiation, while nutrient recovery promotes their differentiation and contributes to accelerated growth. Furthermore, the phosphorylation of Akt in the resting zone is reduced under nutrient deprivation, and exogenous IGF-1 restores the phosphorylation of Akt and stimulates the differentiation of chondroprogenitor cells, leading to a decrease in their numbers.

BONE RESEARCH (2023)

Article Endocrinology & Metabolism

Interspecies Single-Cell RNA-Seq Analysis Reveals the Novel Trajectory of Osteoclast Differentiation and Therapeutic Targets

Yasunori Omata, Hiroyuki Okada, Steffen Uebe, Naohiro Izawa, Arif B. Ekici, Kerstin Sarter, Taku Saito, Georg Schett, Sakae Tanaka, Mario M. Zaiss

Summary: Bone turnover is regulated by a variety of bone cells, including osteoblasts, osteoclasts, and osteocytes. The differentiation and maturation of osteoclasts are crucial for maintaining skeletal homeostasis. Through single-cell RNA sequencing, researchers identified RAB38 as a key molecule involved in osteoclast differentiation and maturation.

JBMR PLUS (2022)

Article Endocrinology & Metabolism

Transcription Factor Hematopoietically Expressed Homeobox Protein (Hhex) Negatively Regulates Osteoclast Differentiation by Controlling Cyclin-Dependent Kinase Inhibitors

Hisato Watanabe, Hiroyuki Okada, Jun Hirose, Yasunori Omata, Takumi Matsumoto, Morio Matsumoto, Masaya Nakamura, Taku Saito, Takeshi Miyamoto, Sakae Tanaka

Summary: We investigated the role of hematopoietically expressed homeobox protein (Hhex) in osteoclast development. Our findings suggest that Hhex acts as an inhibitor of osteoclast differentiation through epigenetic regulation and modulation of the cell cycle of osteoclast precursors. Hhex expression is reduced during RANKL-induced osteoclastogenesis, and overexpression or suppression of Hhex affects the development of osteoclasts in vitro. Conditional deletion of Hhex in osteoclast-lineage cells promotes osteoclastogenesis and reduces cancellous bone volume in mice.

JBMR PLUS (2022)

Article Rheumatology

Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis

Haruka Tsuchiya, Mineto Ota, Shuji Sumitomo, Kazuyoshi Ishigaki, Akari Suzuki, Toyonori Sakata, Yumi Tsuchida, Hiroshi Inui, Jun Hirose, Yuta Kochi, Yuho Kadono, Katsuhiko Shirahige, Sakae Tanaka, Kazuhiko Yamamoto, Keishi Fujio

Summary: Objectives: Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation in the synovium, where synovial fibroblasts (SFs) play a major role. This study aimed to understand the genetic contribution to molecular regulatory networks in SFs under inflammatory conditions. Methods: SFs from RA and osteoarthritis (OA) patients were stimulated with various cytokines and immune cell subsets were analyzed. Integrative analyses including mRNA expression, histone modifications, 3D genome architecture, and genetic variations were performed. Results: Unstimulated SFs from RA patients showed differences in transcriptome and epigenome compared to OA SFs. Most responses to stimulations were shared between the diseases. SFs expressed pathogenic genes and chromatin remodeling in activated SFs revealed enrichment of RA risk loci in clusters of enhancers induced by proinflammatory cytokines. A RA risk SNP formed 3D contact with the promoter of a gene related to arthritis, and inhibition of this gene suppressed cytokine and chemokine production in SFs. Conclusions: This study identified potential therapeutic targets associated with genetic risk of RA and established a dynamic landscape of activated SFs.

ANNALS OF THE RHEUMATIC DISEASES (2021)

暂无数据